多国对婴儿PCV20和PCV15疫苗接种所需人数的比较
Euan Dawson1, Maria J Tort2, An Ta3
1Pfizer Inc., Tadworth KT20 7NS, UK.
Vaccines
|February 26, 2026
概括
新的肺炎球菌联合疫苗 (PCV20和PCV15) 提供了更广泛的保护. 与PCV15相比,PCV20需要为预防疾病接种更少的婴儿疫苗,这表明公共卫生影响更大.
科学领域:
- * 流行病学 流行病学
- * 疫苗学 疫苗学 疫苗学
- * * 公共卫生 公共卫生
背景情况:
- * 婴儿肺炎球菌联合疫苗 (PCV) 降低了疾病负担.
- *较新的疫苗,15-valent (PCV15) 和20-valent (PCV20),提供更广泛的血清型覆盖.
- *PCV15和PCV20与PCV13的比较有效性正在评估中.
研究的目的:
- * 估计婴儿PCV20和PCV15计划中需要接种疫苗的数量 (NNV).
- *在不同国家比较PCV20和PCV15的NNV与PCV13的NNV.
- * 评估PCV20与PCV15.5对公众健康的影响.
主要方法:
- *采用了基于人口的多队列建模方法.
- * 为预防肺炎球菌病例,住院和死亡而计算的累计NNV.
- * 进行了概率灵敏度分析和情景评估以确定稳定性.
主要成果:
- *PCV20在所有结局和国家显示的NNV数量低于PCV15.
- * 预防一个病例的NNV中位数:13 (PCV20) 与80 (PCV15) 相比.
- *PCV15需要比PCV20接种疫苗的4.2至5.1倍,以实现类似的疾病减少.
结论:
- * 婴儿用PCV20免疫接种在预防肺炎球菌病方面比PCV15更有效.
- *由于NNVs较低,PCV20可能会对公共卫生产生更大的影响.
- *研究结果支持PCV20作为婴儿免疫计划中可能更具影响力的选择.
相关概念视频
Vaccinations
52.3K
Overview
52.3K
Drug Dosing: Infants and Children
407
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
407
Relative Risk
2.3K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.3K


